Celebrex (celecoxib) is now approved to help reduce the number of intestinal polyps in certain patients

Celebrex (celecoxib) is now approved to help reduce the number of intestinal polyps in certain patients.

For now it's only for patients with familial adenomatous polyposis (FAP)...but it's also being studied for non-hereditary colon polyps.

Blocking the COX-2 enzyme seems to reduce the blood supply to the polyp and therefore inhibit growth.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote